AAAAAA

   
Results: 1-25 | 26-47
Results: 1-25/47

Authors: Grenzebach, J Schrappe, M Ludwig, VD Parwaresch, R Zimmermann, M Gadner, H Riehm, H Reiter, A
Citation: J. Grenzebach et al., Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy, ANN HEMATOL, 80, 2001, pp. B73-B76

Authors: Cornely, OA Bethe, U Salzberger, B Franzen, C Hartmann, P Steinmetz, T Fatkenheuer, G Seifert, H Diehl, V Schrappe, M
Citation: Oa. Cornely et al., Randomized controlled monocentric comparison of once daily ceftriaxone with tobramycin and cefotaxime three times daily with tobramycin in neutropenic fever, ANN HEMATOL, 80(2), 2001, pp. 103-108

Authors: Schrappe, M
Citation: M. Schrappe, Workshop on minimal residual disease - 9th Expert Meeting for Pediatric Oncology and Hematology, funded by the Kind-Philipp Foundation, Germany, LEUKEMIA, 15(2), 2001, pp. 272-274

Authors: Seeger, K Viehmann, S Buchwald, D Harbott, J Schrappe, M Stary, J Henze, G Trka, J
Citation: K. Seeger et al., Treatment response and residual-disease monitoring in initial and relapsedTEL-AML1 positive childhood ALL, LEUKEMIA, 15(2), 2001, pp. 280-282

Authors: zur Stadt, U Harms, DO Schluter, S Schrappe, M Goebel, U Spaar, H Janka, G Kabisch, H
Citation: U. Zur Stadt et al., MRD at the end of induction therapy in childhood acute lymphoblastic leukemia: outcome prediction strongly depends on the therapeutic regimen, LEUKEMIA, 15(2), 2001, pp. 283-285

Authors: Pasche, S Schrappe, M
Citation: S. Pasche et M. Schrappe, Quality management: Definition and concept, MED KLIN, 96(8), 2001, pp. 497-502

Authors: Schrappe, M
Citation: M. Schrappe, Quality management under the conditions of the actual health legislation situation: an introduction - Political and institutional aspects, MED KLIN, 96(7), 2001, pp. 417-423

Authors: Schrappe, M
Citation: M. Schrappe, The concept of indicators: Central element of quality management, MED KLIN, 96(10), 2001, pp. 642-647

Authors: Lauten, M Stanulla, M Zimmermann, M Welte, K Riehm, H Schrappe, M
Citation: M. Lauten et al., Clinical outcome of patients with childhood acute lymphoblastic leukaemia and an initial leukaemic blood blast count of less than 1000 per microliter, KLIN PADIAT, 213(4), 2001, pp. 169-174

Authors: Uderzo, C Balduzzi, A De Lorenzo, P Valsecchi, MG Gadner, H Klingebiel, T Zimmermann, M Schrappe, M
Citation: C. Uderzo et al., Prospective study on allogeneic bone marrow transplantation (Allo BMT) versus chemotherapy (Chemo) for very high-risk (VHR) childhood acute lymphoblastic leukaemia in first complete remission, BONE MAR TR, 28, 2001, pp. S22-S24

Authors: Scholz, I Popp, S Granzow, M Schoell, B Holtgreve-Grez, H Takeuchi, S Schrappe, M Harbott, J Teigler-Schlegel, A Zimmermann, M Fischer, C Koeffler, HP Bartram, CR Jauch, A
Citation: I. Scholz et al., Comparative genomic hybridization in childhood acute lymphoblastic leukemia: correlation with interphase cytogenetics and loss of heterozygosity analysis, CANC GENET, 124(2), 2001, pp. 89-97

Authors: Brenner, H Kaatsch, P Burkhardt-Hammer, T Harms, DO Schrappe, M Michaelis, J
Citation: H. Brenner et al., Long-term survival of children with leukemia achieved by the end of the second millennium, CANCER, 92(7), 2001, pp. 1977-1983

Authors: Muller, HJ Beier, R Loning, L Blutters-Sawatzki, R Dorffel, W Maass, E Muller-Weihrich, S Scheel-Walter, HG Scherer, F Stahnke, K Schrappe, M Horn, A Lumkemann, K Boos, J
Citation: Hj. Muller et al., Pharmacokinetics of native Escherichia coli asparaginase (Asparaginase medac) and hypersensitivity reactions in ALL-BFM 95 reinduction treatment, BR J HAEM, 114(4), 2001, pp. 794-799

Authors: Seidemann, K Tiemann, M Schrappe, M Yakisan, E Simonitsch, I Janka-Schaub, G Dorffel, W Zimmermann, M Mann, G Gadner, H Parwaresch, R Riehm, H Reiter, A
Citation: K. Seidemann et al., Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90, BLOOD, 97(12), 2001, pp. 3699-3706

Authors: Anderer, G Schrappe, M Brechlin, AM Lauten, M Muti, P Welte, K Stanulla, M
Citation: G. Anderer et al., Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia, PHARMACOGEN, 10(8), 2000, pp. 715-726

Authors: Stanulla, M Kasper, B Schrappe, M Viehmann, S Harbott, J Ludwig, WD Welte, K
Citation: M. Stanulla et al., Granulocyte colony-stimulating factor receptor expression and 11q23/MLL genotype in childhood acute lymphoblastic leukemia developing during the first 18 months of life, LEUKEMIA, 14(2), 2000, pp. 337-338

Authors: Schrappe, M Camitta, B Pui, CH Eden, T Gaynon, P Gustafsson, G Janka-Schaub, GE Kamps, W Masera, G Sallan, S Tsuchida, M Vilmer, E
Citation: M. Schrappe et al., Long-term results of large prospective trials in childhood acute lymphoblastic leukemia, LEUKEMIA, 14(12), 2000, pp. 2193-2194

Authors: Schrappe, M Reiter, A Zimmermann, M Harbott, J Ludwig, WD Henze, G Gadner, H Odenwald, E Riehm, H
Citation: M. Schrappe et al., Long-term results of four consecutive trials in childhood ALL performed bythe ALL-BFM study group from 1981 to 1995, LEUKEMIA, 14(12), 2000, pp. 2205-2222

Authors: Biondi, A Valsecchi, MG Seriu, T D'Aniello, E Willemse, MJ Fasching, K Pannunzio, A Gadner, H Schrappe, M Kamps, WA Bartram, CR van Dongen, JJM Panzer-Grumayer, ER
Citation: A. Biondi et al., Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group, LEUKEMIA, 14(11), 2000, pp. 1939-1943

Authors: Wuchter, C Karawajew, L Ruppert, V Schrappe, M Buchner, T Schoch, C Haferlach, T Harbott, JN Ratei, R Dorken, B Ludwig, WD
Citation: C. Wuchter et al., Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia, HAEMATOLOG, 85(7), 2000, pp. 711-721

Authors: zur Stadt, U Harms, DO Schluter, S Jorch, N Spaar, HJ Nurnberger, W Volpel, S Gutjahr, P Schrappe, M Janka, G Kabisch, H
Citation: U. Zur Stadt et al., Minimal residual disease analysis in acute lymphoblastic leukemia of childhood after an induction therapy without asparaginase, KLIN PADIAT, 212(4), 2000, pp. 169-173

Authors: Cornely, OA Salzberger, B Bethe, U Seifert, H Fatkenheuer, G Diehl, V Schrappe, M
Citation: Oa. Cornely et al., Ceftriaxone and cefotaxime are equally effective in the treatment of neutropenic fever, ANTIB CHEMY, 50, 2000, pp. 37-46

Authors: Valsecchi, MG Schrappe, M Pui, CH
Citation: Mg. Valsecchi et al., Philadelphia chromosome-positive acute lymphoblastic leukemia in children - Reply, N ENG J MED, 343(14), 2000, pp. 1043-1044

Authors: Arico, M Valsecchi, MG Camitta, B Schrappe, M Chessells, J Baruchel, A Gaynon, P Silverman, L Janka-Schaub, G Kamps, W Pui, CH Masera, G
Citation: M. Arico et al., Outcome of treatment in children with philadelphia chromosome-positive acute lymphoblastic leukemia, N ENG J MED, 342(14), 2000, pp. 998-1006

Authors: Szavay, PO Wermes, C Fuchs, J Schrappe, M Flemming, P von Schweinitz, D
Citation: Po. Szavay et al., Effective treatment of infantile choriocarcinoma in the liver with chemotherapy and surgical resection: A case report, J PED SURG, 35(7), 2000, pp. 1134-1135
Risultati: 1-25 | 26-47